The SHARx Difference

The SHARx Difference

Are you familiar with the phrase “guilty by association”? Big Pharma is at it again. They have collectively released their minions to concoct a new moniker: Alternate Funding Programs (AFPs). According to several articles found on the internet, SHARx finds itself lumped into a category that is based on a fictious representation of our business…

The Solution to High-Cost Drug Pricing in the U.S.: Having the Right Conversations

The Solution to High-Cost Drug Pricing in the U.S.: Having the Right Conversations

Prescription drugs cost 256% (now at 322%) more in the United States than the rest of the world (RAND Corporation). While shocking, this probably comes as no surprise since the U.S. has held the top spot in prescription drug spend per capita for over a decade. Consumers and employers continue to struggle to keep up…

A New Approach

A New Approach

The Cold Hard Facts According to BenefitsPRO, 93% of employers considered switching pharmacy benefit providers in the last year due to the rising cost of prescriptions and complicated PBM contracts; smaller employers are more likely to re-evaluate their pharmacy benefit plans than very large employers; and future company health plan designs greatly concern majority of…

Taking the Leap

Are You Sure About Insurance for Medications? Insurance was meant to cover the risk of unknown loss. Many Human Resource managers have implemented pharmacy insurance into their companies’ benefits because it has been engrained in them that insurance is what you do for your employees. However, in doing so, they are often creating a major…

Disrupting the Norm

Disruption Disruption is a good thing! To put it simply, disruption means to break the normal course or continuation of some activity, process, etc. To many, disruption alludes a negative connotation. With disruption comes change. Change is scary because it opens the door to the unknown. I am advocating to change that narrative. Change needs…

Remaining Ethical in an Unethical Climate

Talk is Cheap The pharmaceutical industry has an ethics problem, but if you listen to many of the “talking heads” for Big Pharma, they will have you believe that it is the employers, looking for solutions so they can maintain/achieve financial solvency while doing right by their employees, that are being “unethical”. Under the Insurance…

Into the thick of it: How to be a discerning consultant

Hooked on a Feeling The pharmaceutical industry is addicted to making money. So much so that they refuse the recommendations of experts and doctors to protect their own financial interests. In an industry that should be patient-centric, off kilter priorities have led to decision-making based on profits rather than people. Often, Big Pharma prioritizes things…